In-vitro susceptibility of anaerobic bacteria to gar-936, a new glycylcycline
Open Access
- 1 March 2000
- journal article
- research article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 6 (3) , 159-163
- https://doi.org/10.1046/j.1469-0691.2000.00034-6.x
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9- t -Butylglycylamido Derivative of Minocycline (GAR-936)Antimicrobial Agents and Chemotherapy, 1999
- Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclinesJournal of Medicinal Chemistry, 1994